Wayfinding Financial’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,134
Closed -$206K 166
2025
Q4
$206K Sell
2,134
-57
-3% -$5.54K 0.09% 150
2025
Q3
$210K Buy
+2,191
New +$201K 0.09% 147
2025
Q2
Sell
-3,024
Closed -$273K 495
2025
Q1
$273K Buy
+3,024
New +$271K 0.12% 106
2023
Q3
Sell
-2,411
Closed -$212K 114
2023
Q2
$212K Sell
2,411
-125
-5% -$10.8K 0.15% 110
2023
Q1
$206K Buy
+2,536
New +$207K 0.16% 101

Other funds holding MDT

Wayfinding Financial's MDT Position: Q1 2026 in Review

Wayfinding Financial sold out of Medtronic (MDT) in Q1 2026, closing a stake of 2,134 shares — an estimated $206K sold.

Wayfinding Financial first reported a position in MDT in Q1 2023 and held it in 5 quarters. The position peaked at $273K in Q1 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Wayfinding Financial reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
  • Wayfinding Financial sold 2,134 Medtronic shares in Q1 2026, an estimated $206K.
  • Wayfinding Financial first reported a position in Medtronic in Q1 2023 and held it in 5 quarters.
  • Wayfinding Financial's Medtronic position peaked at $273K in Q1 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Wayfinding Financial's 13F filing for Q1 2026, filed 12 May 2026.